Skip to main content

Table 1 The clinicopathological characteristics of 93 patients with bladder cancer

From: The prognostic impact of GSTM1/GSTP1 genetic variants in bladder Cancer

The clinicopathological characteristics

N

%

Group age (Years)

≤60

37

39.78%

> 60

55

59.14%

Unknown

1

1.08%

Gender

Male

77

82.80%

Female

16

17.20%

Tumor Grade

High Grade

56

60.22%

Low Grade

29

31.18%

Unknown

8

8.60%

Cancer type

MIBC

52

55.91%

NMIBC

28

30.11%

Unknown

13

13.98%

Subtypes

Transitional

74

79.57%

Squamous

3

3.23%

Transitional/ Squamous

15

16.13%

Unknown

1

1.08%

Tumor Shape

Papillary

63

67.74%

Non-papillary

3

3.23%

Unknown

27

29.03%

Lymph Node

Positive

21

22.58%

Negative

68

73.12%

Unknown

4

4.30%

Vascular Invasion

Positive

18

19.35%

Negative

70

75.27%

Unknown

5

5.38%

Metastasis

Positive

21

22.58%

Negative

67

72.04%

Unknown

5

5.38%

Smoking

No

11

11.83%

Yes

16

17.20%

Unknown

66

70.97%

Family history of cancer

No

24

25.81%

Yes

4

4.30%

Unknown

65

69.89%

Survival

Alive

65

69.89%

Deceased

28

30.11%

  1. Abbreviation: MIBC Muscle Invasive Bladder Cancer, NMIBC Non-Muscle Invasive Bladder Cancer